Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 296-301

  Guerreiro, J B ^a   Santos, S B ^a   Morgan, D J ^b   Porto, A F ^a   Muniz, A L ^a   Ho, J L ^b   Teixeira Jr , A L ^c   Teixeira, M M ^c   Carvalho, E M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

CCL2; Chemokines; CXCL10; HAM TSP; HTLV 1

Indexed keywords

CHEMOKINE; CHEMOKINE CCL24; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMA PROTEIN; TAX PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CIRCULATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T LYMPHOCYTE ACTIVATION; TROPICAL DISEASE; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CARRIER STATE; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON TYPE II; PARAPARESIS, TROPICAL SPASTIC; STATISTICS, NONPARAMETRIC;

EID: 33745946080     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03150.x     Document Type: Article

References (37)

1. Carvalho EM, Bacellar O, Porto AF, Braga S, Galvao-Castro B, Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001; 27:1-6.
2. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000; 18:109-19.
3. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15:15-37.
4. Biddison WE, Kubota R, Kawanishi T et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997; 159:2018-25.
5. Santos SB, Porto AF, Muniz AL et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004; 4:7.
6. Hickey WF. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991; 1:97-105.
7. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186 (Suppl. 2):S187-92.
8. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 2001; 65:131-50.
9. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18:217-42.
10. Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer 1996; 66:124-9.
11. Salmaggi A, Gelati M, Dufour A et al. Expression and modulation of IFN-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res 2002; 22:631-40.
12. Ransohoff RM. The chemokine system in neuroinflammation: an update. J Infect Dis 2002; 186 (Suppl. 2):S152-6.
13. Asensio VC, Campbell IL. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 1999; 22:504-12.
14. Fife BT, Kennedy KJ, Paniagua MC et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2001; 166:7617-24.
15. Biernacki K, Prat A, Blain M, Antel JP. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol 2001; 60:1127-36.
16. Biernacki K, Prat A, Blain M, Antel JP. Regulation of cellular and molecular trafficking across human brain endothelial cells by Th1 and Th2-polarized lymphocytes. J Neuropathol Exp Neurol 2004; 63:223-32.
17. Trebst C, Ransohoff RM. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Arch Neurol 2001; 58:1975-80.
18. Teixeira AL Jr, Cardoso F, Souza AL, Teixeira MM. Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients. J Neuroimmunol 2004; 150:157-62.
19. Narikawa K, Fujihara K, Misu T et al. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha. J Neuroimmunol 2005; 159:177-82.
20. Osame M. Review of WHO Kagoshima meeting and diagnosis guidelines from HAM/TSP. In Blatter WA, ed. Human retrovirology: HTLV. New York: Rayen Press, 1990:191-7.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
22. Falcao PL, Correa-Oliveira R, Fraga LA et al. Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J Infect Dis 2002; 186:1696-700.
23. Narumi S, Wyner LM, Stoler MH, Tannenbaum CS, Hamilton TA. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon gamma. J Leukoc Biol 1992; 52:27-33.
24. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000; 404:407-11.
25. Goon PKC, Hanon E, Igakura T et al. High frequencies of Th1-type CD4+ T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002; 99:3335-41.
26. Mahad DJ, Howell SJL, Woodroofe MN. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72:498-502.
27. Neva FA, Filho JO, Gam AA et al. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 1998; 178:1856-9.
28. Porto AF, Neva FA, Bittencourt H et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23:503-7.
29. Porto AF, Santos SB, Alcantara L et al. HTLV-1 modifies the clinical and immunological response to schistosomiasis. Clin Exp Immunol 2004; 137:424-9.
30. Huang D, Han Y, Rani MR et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 2000; 177:52-67.
31. Sorensen TL, Trebst C, Kivisakk P et al. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol 2002; 127:59-68.
32. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28:254-60.
33. Wekerle H, Sun D, Oropeza-Wekerle RL, Meyermann R. Immune reactivity in the nervous system, modulation of T-lymphocyte activation by glial cells. J Exp Biol 1987; 132:43-57.
34. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36:118-24.
35. Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame M. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol (Berl) 1996; 91:343-50.
36. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 1997; 150:617-30.
37. Franciotta D, Martino G, Zardini E et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 2001; 115:192-8.